BioServe and NGC Medical SpA Launch BioServe-Europe

BioServe-Europe provides comprehensive pre-clinical molecular services and biospecimens to European life science researchers

10-Aug-2010

BioServe and NGC Medical SpA announced the opening of BioServe-Europe. Based in Milan, Italy BioServe-Europe provides the European life science research industry with molecular services, including the processing of new personal genetic tests, high-throughput genotyping, and DNA and RNA extractions. In addition, BioServe-Europe distributes biospecimens from its Global BioRepository and biobank partner network, as well as samples sourced from within the EU.

"The combination of cutting edge genomic services and high-quality biosamples has proven to be a powerful offering for the scientific community in North America. Our recent foray in the EU market, working with NGC Medical, has revealed a similar strong demand for these unique services," said Rama Modali, President, BioServe.

Modali added, "The EU market is also quickly adopting new in-vitro diagnostic tests as part of a move to a personalized medicine regime. BioServe-Europe's genomic services have the ability to a key component in the processing and validation of these tests' results."

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance